Anthony Bhatt

Anthony Bhatt is a leader in late effects research for Hodgkin lymphoma survivors, who face elevated risks of secondary cancers, cardiac disease, and pulmonary toxicity from treatment. His research quantified the dose-response relationships between mediastinal radiation and subsequent breast cancer and coronary artery disease risk. He has contributed to developing late effects surveillance guidelines and risk-stratified screening programs for Hodgkin survivors. His work provides the evidence base for modernizing Hodgkin therapy to reduce late toxicities while maintaining cure rates.